Promising schizophrenia drug studied in adolescents
NCT ID NCT04779177
First seen Nov 12, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This study looked at how safe and tolerable the drug lumateperone is for teenagers aged 13 to 17 with schizophrenia or schizoaffective disorder. Researchers gave the drug to 26 teens and monitored side effects and how the drug moves through the body. The goal was to gather early safety data, not to measure how well it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site
Hollywood, Florida, 33024, United States
-
Clinical Site
Atlanta, Georgia, 30331, United States
-
Clinical Site
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.